Abstract：OBJECTIVE: To assess the outcome of childhood hepatoblastoma after a combination therapy of resection and chemotherapy. METHODS: The clinical data of 14 children with hepatoblastoma was retrospectively reviewed. Their long-term survival was followed-up. RESULTS: Twelve cases received surgery and planned chemotherapy. The follow-up duration averaged 18 months (range 1.5-74 months). Nine survived free of events, 1 died, 1 survived with multiple lung metastases, and 1 with increased alpha-fetoprotein (AFP) content but without residual tumor. CONCLUSIONS: Surgery assisted with chemotherapy can improve the outcome of hepatoblastoma.［Chin J Contemp Pediatr, 2009, 11 (6):456-459］
［4］Tiao GM, Bobey N, Allen S, Nieves N, Alonso M, Bucuvalas J, et al. The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation［J］. J Pediatr, 2005, 146(2): 204-211.
［5］Towu E, Kiely E, Pierro A, Spitz L. Outcome and complication after resection of hepatoblastoma［J］. J Pediatr Surg, 2004, 39(2): 199-202.
［6］Roebuck DJ, Aronson D, Clapuyt P, Czauderna P, de Ville de Goyet J, Gauthier F, et al. 2005 PRETEXT:a revised staging system for primary malignant liver tumors of childhood developed by the SIOPEL group［J］. Pediatr Radiol, 2007, 37(2):123-132.
［7］Czauderna P, Otte JB, Roebuck DJ, von Schweinitz D, Plaschkes J. Surgical treatment of hepatoblastoma in children［J］. Pediatr Radiol, 2006, 36(3):187-191.
［8］Perilongo G, Shafford E, Maibach R, Aronson D, Brugieres L, Brock P, et al. Risk-adapted treatment for childhood hepatoblastoma: final report of the second study of the International Society of Pediatric Oncology-SIOPEL 2［J］. Eur J Cancer, 2004, 40(3): 411-421.
［9］Ortega JA, Douglass EC, Feusner JH, Marleta R, John JQ, Milton JF, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusioin doxorubicin for treatment of pediatric hepatoblastoma: a report from the children′s cancer group and the pediatric oncology group［J］. J Clin Oncol, 2000, 18(14):2665-2675.
［10］Jiang XW, Li JH, Hu XL, Chen ZX. Combined treatment of hepatoblastoma with transcatheter arterial chemoembolization and surgery［J］. Pediatr Hematol Oncol, 2006, 23(1):1-9.
［11］Malogolowkin MH, Stanly P, Steele DA, Jorge AO. Feasibility and toxicity of chemoembolization for children with liver tumors［J］. J Clin Oncol, 2000, 18(6):1279-1284.
［15］De Ioris M, Brugieres L, Zimmermann A, Keeling J, Brock P, Maibach R, et al. Hepatoblastom with a low serum alpha-fetoprotein level at diagnosis: the SOIOPEL group experience［J］. Eur J Cancer, 2008, 44(4):545-550.
［16］D′Antiga L, Vallortigara F, Cillo U, Talenti E, Rugge M, Zancan L, et al. Features predicting unresectability in hepatoblastoma［J］.Cancer, 2007, 110(5):1050-1058.
